Share Name Share Symbol Market Type Share ISIN Share Description
Btg Plc LSE:BTG London Ordinary Share GB0001001592 ORD 10P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.0% 840.00 839.00 840.00 0.00 0.00 - 0.00 00:00:00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Support Services 620.5 -70.6 3.9 215.4 3,261

Btg Share Discussion Threads

Showing 4926 to 4949 of 6225 messages
Chat Pages: Latest  201  200  199  198  197  196  195  194  193  192  191  190  Older
DateSubjectAuthorDiscuss
06/11/2017
07:48
May I remind folk that btg charge $3000 for one can of varithena, yet insurers will only offers $1700 for multiple vein procedure. Shortfall of $1300!
cockneytrader
06/11/2017
07:36
seems like a buying opportunity for some at discounted price then.
ashehzi
06/11/2017
07:17
The good, the bad and the ugly news. Via news. Charges agreed but uncertainty till end of 2018 of impact. Loss of court case and hit of 55 million this half.
bill hunt
06/11/2017
07:15
Shocking! Two awful pieces of news on the same day. Both Products to be written off? Down 10 or maybe 20% on this news.
cockneytrader
05/11/2017
12:34
I can’t see it going much more than £8 but what to I know?
dp1umb
05/11/2017
09:23
Good news indeed dp1umb , maybe a period of golden news nuggets about to be released. Hopefully they can reach a out of court settlement on the recent dispute and move onwards.
bargainbob
05/11/2017
08:59
Bob Zytiga has returned to growth with a 25% increase in sales in the last quarter.
dp1umb
04/11/2017
12:44
Bargain the problem is it’s patent has expired this quarter will be your last revenue unfortunately unless I’ve missed something? I know the zytiga patent is hard to work out but lemtrada was more straight forward. There should also be news soon regarding the lung device which could be earnings enhancing.
dp1umb
04/11/2017
05:42
Think maybe wrong Dave on eye eye eye posted this . I have taken this dater from todays update from Sanofi 3rd quarter sales, and Lemtrada is doing very nicely it's up 5.4% in just this quarter alone . BE HAPPY DAVE , Multiple Sclerosis franchise Net sales (€ million) Q3 2017 Change (CER) 9M 2017 Change (CER) Aubagio® 382 +19.2% 1,178 +26.9%--------------------------------------------------------------------- Lemtrada® 113 +5.4% 362 +18.5%;-------------------------------------------------------------------- Total Multiple Sclerosis 495 +15.7% 1,540 +24.8%.------------------------------------------------ Third-quarter Multiple Sclerosis (MS) sales grew 15.7% to €495 million, driven by Aubagio® performance in the U.S. and Europe. Year-to-date MS sales increased 24.8% to €1,540 million. Third-quarter Aubagio® sales increased 19.2% to €382 million driven by the U.S. (up 20.9% to €274 million). In Europe sales of Aubagio were up 16.0% to €86 million. Year-to-date Aubagio® sales increased 26.9% to €1,178 million. In the third quarter Lemtrada® sales were up 5.4% to €113 million, including €60 million in the U.S. (stable) and €40 million in Europe (up 10.8%). Year-to-date Lemtrada® sales increased 18.5% to €362 million.
bargainbob
03/11/2017
17:24
Bargain your right it’s the codes
dp1umb
03/11/2017
16:07
Bill hunt , the market forgot the liable bill imho , unless someone is stake building , I suspect the price to follow previous years. The issuing of the codes finally could bring support though. Suspect news of this before the 14th.
bargainbob
03/11/2017
15:42
In recent times the price has spiked before the reporting then retraced significantly after. Hope this is not the case this time around.
bill hunt
03/11/2017
15:26
Another decent day today, let’s hope they don’t disappoint. This has been one of my better bio investments
dr biotech
02/11/2017
08:51
BTG...pushing on up to Interims on the 14th Nov. EPS seen increasing 84% and P/E of 25 to 2018, (Hist Low)Numis have a 900p share price Target 😎😃
3rd eye
01/11/2017
08:46
Good progress over the last six weeks- final code values are 'expected' in November for Varithena.If there are no further downsides in the announcements mid month, we could be set for a significant push in growth for 2018.I hope it doesn't end in tears!
fhmktg
27/10/2017
15:02
A very good recovery today
dp1umb
24/10/2017
18:43
a1ord how quick sentiment changes last month this board was all doom and gloom with a lot of longterm holders selling up!i myself being in as low as 75p thought about offloading 50%. Fast forward to Friday and hitting 3 year highs. Do you think there's any chance of that happening over at poor old Vectura ? It's got to turn soon,
dp1umb
24/10/2017
16:54
bb 100k shares of BTG going to 17£ or 1mil. going to 8,5 £. HOPEFULLY 17£ ! :)
a1ord53
21/10/2017
10:54
Stupid article , how many shares are required etc etc .
bargainbob
21/10/2017
09:03
Https://uk.finance.yahoo.com/news/2-pharma-stocks-could-millionaire-081232699.html
bookish
19/10/2017
21:18
Https://simplywall.st/news/2017/10/19/what-do-analysts-think-about-the-future-of-btg-plcs-lsebtg-business/ What Do Analysts Think About the future of BTG plc’s (LSE:BTG) Business? Brandie Wetzel October 19, 2017 BTG plc (LSE:BTG)’s impressive earnings growth per share is expected to be a big 261.58% over the next three years. Presently, with an EPS of £0.087, we can expect an upcoming EPS of £0.316. I am going to look at the latest data on BTG to assess whether this expected growth is reasonable. View our latest analysis for BTG Exciting times ahead for BTG One reason why investors are attracted to BTG is the high growth potential in the near future. The consensus forecast from 9 analysts is extremely positive, with earnings per share estimated to surge from current levels of £0.087 to more than double over the next couple of years. During the same time we should see the revenue grow from £571M to £679M and net income is predicted to shoot up from £34M to £121M in the next couple of years, roughly growing 3.8x. Though, at the current levels of revenue and profit, margins are certainly underwhelming. Chart on site
bookish
19/10/2017
20:35
That is some chart forming
dp1umb
18/10/2017
09:09
BTG Btg yearly and 6 month breakout. Brokers have been bullish recently. eg, 05 Oct 17 Numis Buy 741.00 900.00 900.00 Reiterates. Broker Upgrade --- 17-Oct-2017 05:16:40 - BTG PLC BTG.L: JEFFERIES RAISES TARGET PRICE TO 900P FROM 775P; RATING BUY.
3rd eye
17/10/2017
11:58
Interesting??!!
dp1umb
Chat Pages: Latest  201  200  199  198  197  196  195  194  193  192  191  190  Older
Your Recent History
LSE
BTG
Btg
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20191216 12:22:01